Detalhe da pesquisa
1.
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(18): 1672-1684, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870974
2.
Prognostic Value of HER2 to CEP17 Ratio on Fluorescence In Situ Hybridization Ratio in Patients with Nonmetastatic HER2-Positive Inflammatory and Noninflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy with or without Trastuzumab.
Oncologist
; 25(6): e909-e919, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32003919
3.
Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer.
Breast Cancer Res Treat
; 176(3): 545-556, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31054033
4.
BRCA mutations in women with inflammatory breast cancer.
Cancer
; 124(3): 466-474, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29044548
5.
Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes.
Breast Cancer Res Treat
; 171(2): 501-511, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29915946
6.
Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.
Lancet Oncol
; 18(4): e228-e232, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28368261
7.
High HER2/Centromeric Probe for Chromosome 17 Fluorescence In Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant Systemic Therapy With Trastuzumab for HER2-Overexpressing Locally Advanced Breast Cancer.
Oncologist
; 21(1): 21-7, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26659222
8.
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.
Mod Pathol
; 29(4): 330-46, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26916073
9.
Circulating tumor cells in newly diagnosed inflammatory breast cancer.
Breast Cancer Res
; 17: 2, 2015 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25572591
10.
Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
Breast Cancer Res Treat
; 152(2): 407-16, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26017070
11.
Trends in Metastatic Breast and Prostate Cancer.
N Engl J Med
; 374(6): 595, 2016 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26863371
12.
The role of inflammation in inflammatory breast cancer.
Adv Exp Med Biol
; 816: 53-73, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24818719
13.
Acute myeloid leukemia developing in patients with autoimmune diseases.
Haematologica
; 97(6): 805-17, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22180424
14.
Design and Rationale for a Phase III, Double-Blind, Placebo-Controlled Study of Neoadjuvant Durvalumabâ¯+â¯Chemotherapy Followed by Adjuvant Durvalumab for the Treatment of Patients With Resectable Stages II and III non-small-cell Lung Cancer: The AEGEAN Trial.
Clin Lung Cancer
; 23(3): e247-e251, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34819266
15.
Survival of patients with metastatic breast cancer with or without locoregional therapy.
Lancet Oncol
; 16(16): e585-6, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26678204
16.
Erratum to: Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
Breast Cancer Res Treat
; 152(2): 417, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26092296
17.
The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer.
J Cancer
; 10(12): 2635-2642, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31258771
18.
The 'indirect costs' of underfunding foreign partners in global health research: A case study.
Glob Public Health
; 13(10): 1422-1429, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28920518
19.
Preclinical and phase I clinical studies of KW-2450, a dual IGF-1R/IR tyrosine kinase inhibitor, in combination with lapatinib and letrozole.
Ther Adv Med Oncol
; 10: 1758835918786858, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30083253
20.
Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer.
Surg Clin North Am
; 98(4): 787-800, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30005774